Bio Essence Statistics
Total Valuation
Bio Essence has a market cap or net worth of 13.45 million. The enterprise value is 15.02 million.
| Market Cap | 13.45M |
| Enterprise Value | 15.02M |
Important Dates
The next estimated earnings date is Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bio Essence has 53.81 million shares outstanding. The number of shares has increased by 4.57% in one year.
| Current Share Class | 53.81M |
| Shares Outstanding | 53.81M |
| Shares Change (YoY) | +4.57% |
| Shares Change (QoQ) | +18.26% |
| Owned by Insiders (%) | 63.92% |
| Owned by Institutions (%) | n/a |
| Float | 19.41M |
Valuation Ratios
The trailing PE ratio is 7.08.
| PE Ratio | 7.08 |
| Forward PE | n/a |
| PS Ratio | 4.62 |
| PB Ratio | 5.74 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.36 |
| P/OCF Ratio | 11.36 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.00, with an EV/FCF ratio of 12.69.
| EV / Earnings | 9.90 |
| EV / Sales | 5.16 |
| EV / EBITDA | 9.00 |
| EV / EBIT | 9.76 |
| EV / FCF | 12.69 |
Financial Position
The company has a current ratio of 0.38, with a Debt / Equity ratio of 0.67.
| Current Ratio | 0.38 |
| Quick Ratio | 0.00 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 0.94 |
| Debt / FCF | 1.32 |
| Interest Coverage | 704.01 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 46.74% |
| Return on Invested Capital (ROIC) | 56.83% |
| Return on Capital Employed (ROCE) | 64.18% |
| Weighted Average Cost of Capital (WACC) | 60.40% |
| Revenue Per Employee | 727,876 |
| Profits Per Employee | 379,384 |
| Employee Count | 4 |
| Asset Turnover | 1.41 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Bio Essence has paid 20,250 in taxes.
| Income Tax | 20,250 |
| Effective Tax Rate | 1.32% |
Stock Price Statistics
The stock price has increased by +163.16% in the last 52 weeks. The beta is 11.49, so Bio Essence's price volatility has been higher than the market average.
| Beta (5Y) | 11.49 |
| 52-Week Price Change | +163.16% |
| 50-Day Moving Average | 0.18 |
| 200-Day Moving Average | 0.56 |
| Relative Strength Index (RSI) | 47.88 |
| Average Volume (20 Days) | 8,286 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bio Essence had revenue of 2.91 million and earned 1.52 million in profits. Earnings per share was 0.04.
| Revenue | 2.91M |
| Gross Profit | 2.03M |
| Operating Income | 1.54M |
| Pretax Income | 1.54M |
| Net Income | 1.52M |
| EBITDA | 1.64M |
| EBIT | 1.54M |
| Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has 675 in cash and 1.57 million in debt, with a net cash position of -1.57 million or -0.03 per share.
| Cash & Cash Equivalents | 675 |
| Total Debt | 1.57M |
| Net Cash | -1.57M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 2.34M |
| Book Value Per Share | 0.04 |
| Working Capital | -998,524 |
Cash Flow
| Operating Cash Flow | 1.18M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 235 |
| Net Borrowing | -1.59M |
| Free Cash Flow | 1.18M |
| FCF Per Share | 0.02 |
Margins
Gross margin is 69.68%, with operating and profit margins of 52.86% and 52.12%.
| Gross Margin | 69.68% |
| Operating Margin | 52.86% |
| Pretax Margin | 52.82% |
| Profit Margin | 52.12% |
| EBITDA Margin | 56.42% |
| EBIT Margin | 52.86% |
| FCF Margin | 49.83% |
Dividends & Yields
Bio Essence does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.57% |
| Shareholder Yield | -4.57% |
| Earnings Yield | 11.28% |
| FCF Yield | 8.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |